These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 23098431

  • 1. Serum oncofetal fibronectin (onfFN) mRNA in differentiated thyroid carcinoma (DTC): large overlap between disease-free and metastatic patients.
    Sritara C, Charoenphun P, Ponglikitmongkol M, Musikarat S, Utamakul C, Chokesuwattanasakul P, Thakkinstian A.
    Asian Pac J Cancer Prev; 2012; 13(8):4203-8. PubMed ID: 23098431
    [Abstract] [Full Text] [Related]

  • 2. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E, Musholt PB, Potter E, Petrich T, Wehmeier M, von Wasielewski R, Lichtinghagen R, Musholt TJ.
    Br J Cancer; 2005 Sep 05; 93(5):565-70. PubMed ID: 16091757
    [Abstract] [Full Text] [Related]

  • 3. Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levels.
    Wehmeier M, Petrich T, Brand K, Lichtinghagen R, Hesse E.
    Thyroid; 2010 Jun 05; 20(6):607-13. PubMed ID: 20470202
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Denizot A, Delfino C, Dutour-Meyer A, Fina F, Ouafik L.
    Thyroid; 2003 Sep 05; 13(9):867-72. PubMed ID: 14588101
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G.
    J Endocrinol Invest; 2002 Feb 05; 25(2):110-5. PubMed ID: 11929080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis.
    Hammad MO, Elabbasy LM, Abd Elghaffar MA, Zaki MMA, Bazeed FB, Zahran MA.
    Asia Pac J Clin Oncol; 2019 Oct 05; 15(5):e154-e161. PubMed ID: 30884127
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
    Mariotti S, Barbesino G, Caturegli P, Marinò M, Manetti L, Fugazzola L, Pacini F, Pinchera A.
    J Endocrinol Invest; 1994 Dec 05; 17(11):861-7. PubMed ID: 7745234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM.
    J Clin Endocrinol Metab; 1999 Nov 05; 84(11):4037-42. PubMed ID: 10566646
    [Abstract] [Full Text] [Related]

  • 16. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L, Ceriani L, Ghelfo A, Maffioli M, Keller F.
    Clin Endocrinol (Oxf); 2007 Oct 05; 67(4):547-51. PubMed ID: 17561976
    [Abstract] [Full Text] [Related]

  • 17. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K, Wunderlich G, Liepach U, Koch R, Bredow J, Franke WG.
    Nuklearmedizin; 2001 Oct 05; 40(5):155-63. PubMed ID: 11727628
    [Abstract] [Full Text] [Related]

  • 18. VEGF-D and A Preoperative Serum Levels Predict Nodal and Distant Metastases in Differentiated Thyroid Cancer Patients.
    Lai CW, Duh QY, Chen CW, Chuang FJ, Chang YJ, Lin MT, Wu MH.
    World J Surg; 2015 Jul 05; 39(7):1742-9. PubMed ID: 25670042
    [Abstract] [Full Text] [Related]

  • 19. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ, Kim JY, Park KY, Gong G, Hong SJ, Ahn IM.
    Thyroid; 2000 Mar 05; 10(3):211-7. PubMed ID: 10779135
    [Abstract] [Full Text] [Related]

  • 20. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD, Huang MJ, Juang JH, Chao TC, Huang BY, Chen KW, Chen JY, Li KL, Chen JF, Ho YS.
    Thyroid; 1999 Dec 05; 9(12):1227-35. PubMed ID: 10646663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.